Abstract. Mesenchymal stem cells (MSCs), a stem cell population capable of multi-lineage differentiation, bound to porous biomaterial scaffolds, are widely used for bone tissue regeneration. However, there is evidence to suggest that MSC collection from bone marrow and expansion in vitro may result in phenotypic changes including a loss of differentiation potential and cell senescence. The aim of the present study was to find a facile and efficient approach to enable MSC adhesion and proliferation to scaffolds with osteogenic differentiation. Unprocessed bone marrow blood from the condyle of the distal femur in the rabbits were added to three-dimensional (3D) printed porous poly-ε-caprolactone/hydroxyapatite (PCL/HA) scaffolds with bone marrow clots (MC) formed, using two different methods for Group A (MC enriched scaffolds) and Group B (MC combined scaffolds), and then were cultured in osteogenic medium for 4 weeks. The scaffolds were assessed macroscopically and microscopically. Scaffold bioactivity and the proliferation and osteogenic differentiation of seeded MSCs were measured. Higher cellular viability and greater cell numbers in the scaffolds at later phases of culture were observed in Group B compared with Group A. In addition, Group B was associated with greater osteoinductivity, alkaline phosphatase activity and bony nodule formation, as assessed using scanning electron microscopy. Furthermore, reverse transcription-quantitative polymerase chain reaction analysis revealed that more osteogenic differentiation was present in Group B, compared with Group A. MC combined scaffolds proved to be a highly efficient, reliable and simple novel method for MSC adhesion, proliferation and differentiation. The MC combined PCL-HA multi-scale porosity scaffold may represent a candidate for future bone regeneration studies.
Introduction
Mesenchymal stem cells (MSCs) are of particular interest for therapeutic applications in tissue engineering, as they can differentiate into a number of lineages including chondrocytes, adipocytes and osteoblasts (1) . MSCs exist in very low numbers in the highly cellular and heterogeneous bone marrow, and lack unique identifying markers necessary for definitive isolation. Standard protocols for the isolation of MSCs from the bone marrow include extraction of whole bone marrow, density gradient centrifugation and expansion of the mononuclear cell fraction on tissue culture polystyrene. While this protocol is well accepted for the use of MSCs, there is evidence to suggest that this expansion phase may result in phenotypic changes in MSCs, including a loss of differentiation potential and cell senescence (2, 3) . The use of biomaterials for the incorporation and expansion of MSCs in a three-dimensional (3D) environment is of growing interest in the field, with several successful attempts to expand MSCs three-dimensionally with the use of micro carriers under dynamic conditions (4) (5) (6) . However, these strategies do not eliminate the need for initial culture on plastic.
Marrow clots (MCs), formed by unprocessed bone marrow blood (UBMB) agglutination, provided a simple, convenient and relatively inexpensive biomimetic approach for tissue regeneration through MSC delivery and microenvironment modification inside 3D scaffolds (7, 8 Previous studies have demonstrated that poly-ε-caprolactone (PCL), a biodegradable semi-crystalline linear aliphatic polyester, exhibits good mechanical properties (10) . The Food and Drug Administration has approved this material for use as a drug delivery device and suture staple, and it has been extensively investigated as a biomaterial for regenerative medicine (11, 12) . Hydroxyapatite (HA) has been widely investigated as an osteoconductive and inductive biomaterial for use as a porous bone substitute. PCL and HA have been blended to enhance cell proliferation and differentiation (13, 14) . PCL-HA scaffolds with a precisely-controlled macroarchitecture and microstructure can be fabricated using a 3DP technique for bone regeneration (15, 16) .
Furthermore, PCL-HA scaffolds produced by 3DP with suitable MC concentration may serve an important role in bone tissue engineering research. To address these issues, the present study involved preparation of 3DP PCL-HA scaffolds with two different MC concentration procedures, based on our previous findings (9) . The MSC adhesion, proliferation and osteogenesis performance, cultured in osteogenic differentiation medium in vitro, was examined to evaluate the availability of MC concentration 3DP PCL-HA scaffolds for bone regeneration.
Materials and methods
Animals. Female New Zealand white rabbits (n=10; age, 5-6 months old; weight, 2.0-2.5 kg; Animal Core Facility, Nanjing Medical University, Nanjing, Jiangsu, China) were used for bone marrow blood collection using a micro-fracture procedure. Prior to the experiment, all rabbits were housed at room temperature (25˚C), 60% relative humidity and with a 12-h light/dark cycle for 1 week; all animals had free access to food and water. The use of animals in the present study was approved by the Institutional Animal Experiment Committee of Nanjing Medical University (Nanjing, China), and animals were treated according to the US National Institute of Health guidelines (National Institutes of Health, Bethesda, MA, USA). All animals underwent a veterinary examination to evaluate their general health status. All experimental procedures for bone marrow blood collection were performed under anesthesia with ear vein administration of 2% pentobarbital sodium (30 mg/kg; Sigma; Merck KGaA, Darmstadt, Germany).
Scaffold design and fabrication. 3DP PCL-HA porous scaffolds were designed and manufactured as detailed in the following section. The scaffolds were 4 mm in diameter, 2 mm in thickness, had 100% pore interconnectivity and a 500-µm fiber diameter with a 0/45˚/90˚/135˚ laydown pattern of fibers for porous structure following a previously published protocol (17) . In brief, PCL powder (molecular weight ~60,000, 3D Biotek, LLC, North Brunswick, NJ, USA) and HA (Plasma Biotal Ltd., Buxton, UK) were dried separately for 24 h in a vacuum oven at 120˚C and 40˚C, respectively. All chemicals used were of pharmaceutical grade, and the detailed characterization of these materials is previously described (18, 19) . The scaffolds were fabricated using a 60% PCL/HA (by weight) (20) composite and a 3D fused deposition modelling (FDM) micro-fabrication technology (FDM 700 system; Nanjing Songsun Medical Technology Co, Ltd., Nanjing, Jiangsu, China) according to the manufacturer's protocol. Scaffolds (n=80/group) were fabricated with 10 sampled at each time point (day 1, weeks 1, 2 and 4 of in vitro culture; Fig. 1 ).
Preparation of MC concentration PCL-HA scaffold.
A total of 10 rabbits were randomly divided into two groups (n=5 rabbits/group) and used for subsequent experiments. UBMB collection was performed using a micro-fracture procedure bilaterally on the condyle of the distal femur in the rabbits, as previously described (7). The amount of seeded MSCs was calculated following the protocol in our previous study (7, 21) . For the MC enriched group (Group A), the scaffold was immersed and mixed in UBMB retrieved from one rabbit which contained heparin to prevent blood coagulation during the micro-fracture procedure. In brief, the 3DP scaffolds were immersed in UBMB for 1 h without agitation until they were fully enriched with MC, and were then incubated at 37˚C in a 5% CO 2 humidified incubator in L-Dulbecco's modified Eagle's medium (L-DMEM; Gibco; Thermo Fisher Scientific, Inc., Waltham, MA, USA) for 4 days, with the medium changed every 1-2 days until clear. For the MC combined group (Group B), the scaffold was plugged into the micro-fracture hole at the condyle of the distal femur until full of UBMB, and the MC formed. The scaffolds were then cultured in L-DMEM in the same manner as those in Group A (Fig. 2 ). Then two groups were cultured in osteogenic medium (Gibco; Thermo Fisher Scientific Inc.), supplemented with high-glucose DMEM, 10% fetal bovine serum (both Gibco; Thermo Fisher Scientific, Inc.), 1% penicillin-streptomycin, 10 mmol/l β-glycerophosphate, 50 µM ascorbic acid and 100 nM dexamethasone, for 28 days. A total of 10 samples were tested at each time point for each group at day 1 and at weeks 1, 2 and 4 of in vitro culture.
Macro and micro-morphology observation. The macro morphology of the cultured scaffolds was observed using an inverted microscope (IM) and a digital camera. The micro-structural morphology was observed using a scanning electron microscope (SEM; JEOL, Ltd., Tokyo, Japan), as in our previous study (9) . In brief, specimens were fixed in 2.5% glutaraldehyde overnight, dehydrated using a series of graded ethanol solutions, dried overnight at room temperature and gold sputtered. SEM observation was then performed at an accelerating voltage of 5 keV.
Cell viability and proliferation assessment. Cell viability was assessed using a Live/Dead Reduced Biohazard Viability/Cytotoxicity kit (Molecular Probes; Thermo Fisher Scientific, Inc.) as in our previous study (9) . Samples from each group were assessed at day 1, 14 and 28. In brief, samples were washed using phosphate buffered saline, incubated in the dilute dye solution for 15 min in the dark at room temperature and then fixed in 4% glutaraldehyde for 1 h. These samples were observed and imaged using a confocal microscope (Leica T7100M Confocal Microscope, Leica Microsystems GmbH, Wetzlar, Germany). Live cells were stained green and dead cells were stained red.
A MTT cell proliferation assay kit (Roche Applied Science, Penzburg, Germany) was used to assess proliferation of the cells on the scaffolds, following the protocol supplied by the manufacturer. After 1, 7, 14 and 28 days of cell culture, 20 µl MTT reagent was added to each well of the microtiter plates containing the scaffolds, and cells were incubated for 4 h at 37˚C. After 200 µl solubilization solution (DMSO; Roche Diagnostics, Indianapolis, IN, USA) was added to each well, the plates were incubated overnight. The absorbance was measured at 595 nm using a microplate reader (Bio-Rad Laboratories, Inc., Hercules, CA, USA).
Osteogenic differentiation analyses of the scaffolds. The intracellular alkaline phosphatase (ALP) activity on the cultured scaffolds was compared between the two groups on days 0, 7, 14 and 28 to estimate cell differentiation. Cell lysates were tested for ALP activity using a SensoLyte™ pNPP Alkaline Phosphatase Assay kit (AnaSpec, Fremont, CA, USA) according the manufacturer's protocol. The absorbance was measured at 415 nm using a microplate reader (Bio-Rad Laboratories, Inc.) (22) .
Reverse transcription-quantitative polymerase chain reaction (RT-qPCR).
The expression levels of osteogenic genes on days 14 and 28 were measured using RT-qPCR. The scaffolds were lysed using TRIzol (Invitrogen; Thermo Fisher Scientific, Inc.). The samples in TRIzol were incubated at -80˚C until RNA isolation. Total RNA was isolated and reverse transcribed to cDNA using a High-Capacity cDNA Reverse Transcription Figure 1 . Manufacturing a 3D PCL-HA porous scaffold. The fabricated PCL-HA scaffolds matched the design parameters established using CAD. The 3D fiber porous structure as observed using an inverted microscope and a scanning electron microscope. PCL-HA, poly-ε-caprolactone-hydroxyapatite. Figure 2 . Marrow clots blended with a poly-ε-caprolactone/hydroxyapatite scaffold using two different procedures. In Group A, the scaffold was immersed in unprocessed bone marrow blood for 1 h without agitation until MC were obtained in each structure. In Group B, the scaffold was plugged into a micro-fracture hole at the condyle of the distal femur until full with unprocessed bone marrow blood and a MC formed. The scaffolds were cultured in vitro and 10 samples were analyzed at day 1, and 1, 2 and 4-week time-points. MC, marrow clots. kit (Applied Biosystems; Thermo Fisher Scientific, Inc.). qPCR was performed for the quantification of gene expression using the primers listed in Table I in an ABI Prism 7500 sequence detection system (Applied Biosystems; Thermo Fisher Scientific, Inc.). The target genes osteopontin (OPN), osteocalcin (OCN) and core binding factor α1 (Cbfα1), were normalized against GAPDH expression. Each 20 µl reaction mix contained 10 µl 2X LightCycler ® 480 SYBR Green I Master (Roche Diagnostics, Basel, Switzerland), 10 ng modified DNA and 0.8 µl primer mix (10 pM/µl). qPCR was performed using a LightCycler ® 480 with the following cycling conditions: 95˚C of initial denaturation for 10 min followed by 40 cycles of denaturation at 95˚C for 15 sec, annealing at 60˚C for 1 min, annealing at 62˚C for 10 sec, then polymerization at 72˚C for 20 sec. A melting curve was created by cooling the products at 50˚C for 30 sec and then heating to 80˚C at a rate of 0.1˚C/sec, while simultaneously measuring the fluorescence. Data were analyzed via the comparative quantitation cycle (Cq) method (23) . ΔCq values were first calculated using the formula: ΔCq=Cq Target gene -Cq GAPDH ; then the mean level of target gene (2 -ΔCq ) in all samples was determined.
Histology staining. For Alizarin Red staining, cells on scaffolds were fixed using 3.7% formaldehyde for 24 h at 37˚C and then stained with Alizarin Red S (Nanjing KeygGen Biotech Co., Ltd., Nanjing, China) for 15 min at 25˚C. Scaffolds were washed five times using deionized water to remove excess stain and then air-dried. The morphology of the stained scaffolds was assessed using a digital camera.
Statistical analysis. All statistical analysis was performed using SPSS 13.0 statistical software (SPSS Inc., Chicago, IL, USA). Data are presented as the mean ± standard deviation. The difference between the groups was analyzed by one-way analysis of variance and a Student-Newman-Keuls post hoc test. P<0.05 was considered to indicate a statistically significant difference.
Results
Scaffold characterization. The fabricated PCL-HA scaffolds, a 100% pore interconnectivity and 500 µm fiber diameter with a 0/45˚/90˚/135˚ laydown pattern of fibers for porous structure cylinder with a 4-mm diameter and a 2-mm height, matched the design parameters as assessed through IM and SEM observations. The gross scaffold morphology and cross sectional view of the composite are presented in Fig. 1 .
Observation of macro and micro-structure of the scaffold. SEM imaging revealed that the pores of the scaffolds were filled and obstructed by fibroblast-like tissue, monocytes and erythrocytes at day 1 in Groups A and B (Fig. 3) . Further observation of the scaffold morphology revealed that most erythrocytes and UBMB matrix inside the scaffold pores were washed off after 1 week in normal culture medium in both groups. There was a decrease in the red coloration of the scaffolds, which was more pronounced in scaffolds in Group A.
As time progressed, a gradual accumulation of extracellular matrix (ECM) was observed in both groups. Meanwhile, the density of the scaffold content gradually increased with a subsequent increase of the matrix in the pores during the culture period, as assessed using IM observations (data not shown).
Cell adhesion and proliferation.
A cell viability assessment using confocal imaging of live/dead assay samples demonstrated that green-stained live cells in Group B were apparently increased at the 4-week in vitro time-point, compared with those in Group A. The pore obstruction and recanalization could also be observed in the confocal images (Fig. 4A) . Cell proliferation on the scaffolds was assessed using an MTT assay (Fig. 4B) . The optical density (OD) values were similar in the two groups during the first 14 days of culture. At day 28, the OD values were higher in Group B. The ratio of living cells was the same as the MTT values. Therefore, the MC combined scaffold was considered to be more effective for cell adhesion and proliferation.
Biochemical analyses of the scaffolds. ALP activity was measured to examine the osteogenic differentiation of MSCs on the scaffolds (Fig. 5A) . ALP activity gradually increased with time. The ALP activity of Group B was significantly greater compared with Group A, compared at day 28 (P<0.05). SEM images of the scaffolds at day 28 ( Fig. 5B ) demonstrate higher mineralization in the Group B scaffolds, which corroborates with the ALP activity results. The expression levels of osteogenic genes on days 14 and 28 were measured using RT-qPCR (Fig. 5C ). Group B demonstrated a higher mean expression of Cbfα1 compared with Group A on day 14. However, Cbfα1 expression in Group B on day 28 was lower than in Group A. The mRNA expression levels of OPN and OCN in both Group A and B gradually increased during in vitro culture, with the level of expression in Group B being significantly higher than in Group A ( Fig. 5C ; P<0.05).
Alizarin Red S staining. When cultured in the osteogenic supplements, MSCs in both groups calcified their matrix by day 28 (Fig. 5D ). Calcification is a standard marker for osteogenesis and osteogenic differentiation, and can be assessed using Alizarin Red S staining. The staining in Group B was visibly darker than in Group A. Controls using empty scaffolds without MSCs did not mineralize, indicating that the mineralization was mediated by the MSCs and was not a result of non-specific calcium precipitation.
Discussion
Bone marrow cell systems include both non-hematopoietic stromal cells and hematopoietic cells. The stromal functions as a scaffold, composed of a network of cells that provide physical and functional support to the hematopoietic cells. The stromal fraction, characteristically, is able to adhere to tissue culture plastic, while the non-adherent hematopoietic cells can be readily removed from the adherent stromal cell cultures using a simple wash step (24) . From the SEM and live/dead confocal images of the two groups, the present study demonstrated that the pores of the scaffolds were filled with cells and erythrocytes from the MC at day 1. During the following culture, erythrocytes and other non-adherent hematopoietic cells were gradually eluted. This may have caused the red color to fade and the initially observed decrease in the live/dead cell ratio. An increase in the live/dead cell ratio was observed in both groups at the 2-week time-point, with MSC proliferation. However, in the MC combined PCL-HA scaffolds, gradual cell proliferation was observed over time, which may have caused a higher live/dead cell ratio and a lower cell/ECM ratio during culture, compared with Group A. The present study compared two different methods of MC concentration by observing cell adhesion and proliferation. The results demonstrated more stem cell adhesion and proliferation and improved osteogenic differentiation properties in the scaffold combined with UBMB. In the MC-enriched scaffold group, heparin was used to interfere with the blood clotting process during the micro-fracture procedure. Ultimately, heparin prevented the conversion of fibrinogen into fibrin, resulting in preventing blood coagulation. However, when clotting was not impaired, the fibrin formed bridge shaped structures both along the rods and across the pores of the scaffolds combined with BMB clots, thereby promoting cell adhesion in these scaffolds.
Previous investigations of 3D fabricated porous scaffolds have demonstrated that the formation of new tissues is greatly influenced by the pore size, porosity and the 3D structure of the scaffold (11, 25) . Synthetic scaffolds for bone regeneration must be a 3D structure with interconnected porosity and appropriate pore sizes to assure good vascularization, nutrient delivery and cell attachment in growth (26) (27) (28) . A large pore size is necessary to deliver a sufficient number of cells, and interconnected porosity is required for the easy diffusion of nutrients. Previous studies have suggested that a small pore size improves bone growth into scaffolds and provides attachment points for osteoblasts (29) . The present study fabricated a PCL/HA scaffold with macro and micro porosity for osteogenic differentiation.
In the present study, the ALP activity in Group B was significantly increased compared with Group A. Similarly, RT-qPCR demonstrated that that the expression of OCN and OPN in Group B was higher than in Group A. Cbfα1 expression was higher in Group B at day 14, but the expression of Cbfα1 in the two groups gradually decreased over time, and the expression in Group A was slightly higher than in Group B at day 28. Cbfα1 inhibits the transition of osteoblasts to osteocytes and thereby maintains osteoblastic cells at an immature stage and effectively directs the formation of immature bone. Normally, the expression of Cbfα1 is first detected in pre-osteoblasts and is upregulated in immature osteoblasts, but downregulated in mature osteoblasts (30, 31) . The present study demonstrated that Group B exhibited a greater osteogenetic capacity than Group A. This may be because the UBMB concentration method used in Group B had a significant effect on cell adhesion and osteogenesis compared with Group A, which was demonstrated by the cell proliferation assay and the Alizarin Red S staining. Perhaps the different concentration of growth factors in the MC also attribute to the osteogenetic difference, which requires checking in future studies.
There are some limitations to the present study. The difference between the two different coagulation methods in UBMB was not determined. Whether there is a significant change in the blood composition of the bone marrow after the addition of heparin needs to be clarified by further research. Although MC-PCL-HA demonstrated good osteogenic properties in vitro, the performance of the MC-PCL-HA scaffolds in autologous in vivo studies requires further investigation. The composition of the UBMB is complex. Though most of the non-adherent cells were eluted in culture, residual cellular constituents remained in the pores of the scaffold, which is much closer to the autogenous bone repair process. Furthermore, as an autologous procedure, MC may circumvent the barriers encountered in allograft procedures, including immune rejection, pathogen transmission, issues with packaging, storage and shipping, and difficulties in clinical adoption.
In conclusion, MC-combined scaffolds proved to be a highly efficient, reliable and simple novel method for MSC adhesion, proliferation and osteogenic differentiation. The MC-combined PCL-HA multi-scale porosity scaffold can be a candidate for future bone regeneration studies.
